Correction: Population Pharmacokinetic Analysis of Tucatinib in Healthy Participants and Patients with Breast Cancer or Colorectal Cancer

Clin Pharmacokinet. 2024 Dec 11. doi: 10.1007/s40262-024-01458-0. Online ahead of print.

Authors

Daping Zhang¹, Adekemi Taylor², Jie Janet Zhao², Christopher J Endres^{1

3}, Ariel Topletz-Erickson⁴

Affiliations

¹ Pfizer Inc., 21717 30th Dr SE, Bothell, WA, 98021, USA.
² Integrated Drug Development, Certara USA, Princeton, NJ, USA.
³ Immunome, Exton, PA, USA.
⁴ Pfizer Inc., 21717 30th Dr SE, Bothell, WA, 98021, USA. Ariel.Erickson@pfizer.com.

PMID: 39661316
DOI: 10.1007/s40262-024-01458-0

No abstract available

Publication types

Published Erratum